Stock data
漢康-KY創 (7827)
漢康-KY創 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$0.00M, down 100.0% from a year earlier. EPS over the last four quarters totals -NT$4.33.
Company profile
Data as of 2026-10-18
- Market
- TWSE-listed
- Industry
- Biotech & Medical Care
- Listed
- 2026-05-29
- Founded
- 2020-11-11
- Paid-in capital
- NT$1.41B
- Common shares issued
- 140,887,437
- Legal name
- 英屬開曼群島商漢康生技(股)公司
- Website
- https://www.hanchorbio.com
Monthly revenue
Data as of 2026-10-17
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$0.00M | — | -100.0% |
| 2026-08 | NT$0.00M | -100.0% | — |
Year to date: -91.1% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | -1.88 |
| 2026 Q1 | -2.10 |
| 2025 Q4 | -0.94 |
| 2025 Q3 | 0.59 |
Last four quarters: -NT$4.33
Dividends
Data as of 2026-10-18
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 0.00 | 0.00 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 616 | 0.1% |
| 1,000–5,000 shares | 1,241 | 1.9% |
| 5,001–10,000 shares | 249 | 1.4% |
| 10,001–15,000 shares | 115 | 1.0% |
| 15,001–20,000 shares | 85 | 1.1% |
| 20,001–30,000 shares | 71 | 1.3% |
| 30,001–40,000 shares | 44 | 1.1% |
| 40,001–50,000 shares | 29 | 0.9% |
| 50,001–100,000 shares | 69 | 3.4% |
| 100,001–200,000 shares | 40 | 3.9% |
| 200,001–400,000 shares | 20 | 4.2% |
| 400,001–600,000 shares | 9 | 3.2% |
| 600,001–800,000 shares | 3 | 1.4% |
| 800,001–1,000,000 shares | 1 | 0.7% |
| 1,000,001+ shares | 17 | 74.4% |
TDCC data for 2026-10-16: 17 holders own more than 1,000 lots (74.4% of shares), and 616 hold less than one lot (0.1%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | -56 | 0 | 1 | -55 |
| 2026-10-16 | 59 | 0 | 0 | 59 |
| 2026-10-15 | 26 | 0 | 0 | 26 |
| 2026-10-14 | 56 | 0 | -2 | 54 |
| 2026-10-13 | 28 | 0 | 2 | 30 |
| 2026-10-12 | -47 | 0 | 2 | -45 |
| 2026-10-08 | 188 | 0 | -5 | 183 |
| 2026-10-07 | -118 | 0 | 4 | -114 |
| 2026-10-06 | 138 | 0 | 2 | 140 |
| 2026-10-05 | 25 | 0 | 0 | 25 |
| 2026-10-02 | 18 | 0 | -2 | 16 |
| 2026-10-01 | 33 | 0 | 0 | 33 |
| 2026-09-30 | 43 | 0 | -2 | 41 |
| 2026-09-29 | -53 | 0 | 0 | -53 |
| 2026-09-24 | 13 | 0 | 2 | 15 |
| 2026-09-23 | 3 | 0 | 0 | 3 |
| 2026-09-22 | 177 | 0 | 1 | 178 |
| 2026-09-21 | 114 | 0 | 3 | 117 |
| 2026-09-18 | 161 | 0 | -1 | 160 |
| 2026-09-17 | 59 | 0 | -2 | 57 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 870 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$156.50 (2026-10-19).
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.